SCHEMBL860658

SCHEMBL860658

C=CCc1nc2ccccc2c(=S)[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
HPGD P15428 2/20 0.42
HTT P42858 1/20 0.42
KDM4E B2RXH2 3/20 0.41
RAB9A P51151 3/20 0.41
TNKS2 Q9H2K2 2/20 0.41
PDE10A Q9Y233 1/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PARP1 P09874 3/20 0.37
PARP2 Q9UGN5 1/20 0.37
POLB P06746 1/20 0.36
GAA P10253 1/20 0.36
TNKS O95271 1/20 0.36
NPC1 O15118 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1586638 0.81 TNKS2 (0.64) ALDH1A1KMT2AMEN1HPGDHTT
SCHEMBL10144731 0.77 KMT2A (0.66) KMT2AMEN1KDM4ERAB9AMAPT
SCHEMBL463268 0.76 DDAH1 (0.59) ALDH1A1KMT2AMEN1HPGDRAB9A
Hydrogen Sulfide SCHEMBL29094907 0.75 DDAH1 (0.58) ALDH1A1KMT2AMEN1HPGDRAB9A
Iodide SCHEMBL29040436 0.75 DDAH1 (0.58) ALDH1A1KMT2AMEN1HPGDRAB9A
SCHEMBL28633738 0.75 DDAH1 (0.58) ALDH1A1KMT2AMEN1HPGDRAB9A
Biphenyl SCHEMBL28917228 0.74 GAA (0.54) ALDH1A1KMT2AMEN1HPGDRAB9A
SCHEMBL29212566 0.72 PDE10A (0.40) ALDH1A1KMT2AMEN1HPGDHTT
SCHEMBL9228130 0.71 ALDH1A1 (0.39) ALDH1A1KMT2AMEN1HPGDHTT
Carbamic Acid SCHEMBL7194349 0.71 CHRM1 (0.56) ALDH1A1HTTKDM4ERAB9APDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143252-B2 Tetrahalogenated compounds useful as inhibitors of angiogenesis THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2012-03-27 US disclosed